NUCLEAR: open call for PhD students in metabolic regulation of genome function February 14, 2025 NUCLEAR: open call for PhD students in metabolic regulation of genome function
The Josep Carreras Institute brings science closer to hospitalised children April 29, 2024 The Josep Carreras Institute brings science closer to hospitalised children
Vincenzo Calvanese: “I want to know what makes a stem cell… a stem cell” April 11, 2024 Vincenzo Calvanese: “I want to know what makes a stem cell… a stem cell”
The last trick of p53: early 3D chromatin remodelling to trigger cellular stress response April 05, 2024 The last trick of p53: early 3D chromatin remodelling to trigger cellular stress response
The Josep Carreras Leukaemia Research Institute is accredited as a Severo Ochoa Centre of Excellence March 25, 2024 The Josep Carreras Leukaemia Research Institute is accredited as a Severo Ochoa Centre of Excellence
Researchers find the key to genome-modifying drugs sensitivity in malignant blood diseases March 14, 2024 Researchers find the key to genome-modifying drugs sensitivity in malignant blood diseases
The Spanish Association Against Cancer selects five projects from the Josep Carreras Institute for its 2023 Research Grants March 11, 2024 The Spanish Association Against Cancer selects five projects from the Josep Carreras Institute for its 2023 Research Grants
OneChain Immunotherapeutics receives support to advance a new promising CAR T therapy for a rare leukaemia with no therapeutic alternatives March 04, 2024 OneChain Immunotherapeutics receives support to advance a new promising CAR T therapy for a rare leukaemia with no therapeutic alternatives
Awakening leukaemic stem cells to make them sensitive to chemotherapy February 27, 2024 Awakening leukaemic stem cells to make them sensitive to chemotherapy
The Bigas Lab finds Notch self-inhibition keeps haematopoietic stem cells from differentiate February 23, 2024 The Bigas Lab finds Notch self-inhibition keeps haematopoietic stem cells from differentiate
A new immunotherapy against multiple myeloma shows more effectiveness in experimental models than CAR-T already in use February 14, 2024 A new immunotherapy against multiple myeloma shows more effectiveness in experimental models than CAR-T already in use
-edit-20240304133439.jpg?locale=en)
